PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.00%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-9.66%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-15.10%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-15.10%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-26.87%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-28.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-28.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.84%
Share count expansion well above BIDU's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.71%
Slight or no buyback while BIDU is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
7.39%
OCF growth of 7.39% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
12.38%
FCF growth of 12.38% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
322.21%
10Y revenue/share CAGR under 50% of BIDU's 9029.81%. Michael Burry would suspect a lasting competitive disadvantage.
322.21%
5Y revenue/share CAGR under 50% of BIDU's 873.73%. Michael Burry would suspect a significant competitive gap or product weakness.
153.95%
3Y revenue/share CAGR at 75-90% of BIDU's 196.78%. Bill Ackman would expect new product strategies to close the gap.
329.24%
OCF/share CAGR of 329.24% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
329.24%
OCF/share CAGR of 329.24% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
192.33%
3Y OCF/share CAGR of 192.33% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
90.30%
Below 50% of BIDU's 32009.26%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
90.30%
Below 50% of BIDU's 404.67%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
88.29%
3Y net income/share CAGR above 1.5x BIDU's 29.35%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
408.11%
3Y equity/share CAGR above 1.5x BIDU's 215.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.13%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
4.54%
Asset growth 1.25-1.5x BIDU's 3.09%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
3.03%
50-75% of BIDU's 5.03%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-20.17%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.41%
Our R&D shrinks while BIDU invests at 7.06%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.29%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.